SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : IMDS nasdaq bulletin board -- Ignore unavailable to you. Want to Upgrade?


To: Andrew Abraham who wrote (2947)3/27/1999 11:38:00 AM
From: Labrador  Read Replies (2) | Respond to of 4122
 
what happened to the Lintroscan? Is the company that owns Lintroscan still selling the product internationally?



To: Andrew Abraham who wrote (2947)3/27/1999 11:54:00 AM
From: Labrador  Read Replies (2) | Respond to of 4122
 
Lintronics -- cannot distribute products in U.S., but what happened to overseas sales?

Now I suspect that I (finally) know the reason why the company did not go public with an initial public offering, but rather when the route of purchasing a corporate "shell".

CLASS I RECALLS AND FIELD CORRECTIONS: DEVICES -- Lintronics Technologies, Inc.
08/10/94
FDA Enforcement Report Food & Drug Administration No. 94-3
Copyright 1994 Public Domain

PRODUCT: Breast Transilluminator, Lintroscan Model 200G used for the detection of changes in the breast. Recall Z-1184-4.

CODE: Serial numbers: 080792-02, 082492-03, 082492-04, 01092-05, 01092-06, 01092-07.

MANUFACTURER: Lintronics Technologies, Inc., Tampa, Florida.

RECALLED BY: Manufacturer, by telephone mid November 1993. Firm-initiated recall complete.

DISTRIBUTION: Illinois, Ohio, Georgia, Florida, Virginia.

QUANTITY: 6 units.

REASON: Product labeling fails to bear adequate directions for use. FDA has concluded that transillumination for the examination of the breast is not clinically effective for the diagnosis or detection of breast cancer or other breast abnormalities or conditions.

A Class I recall is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.



To: Andrew Abraham who wrote (2947)3/27/1999 2:29:00 PM
From: Andrew Abraham  Respond to of 4122
 
According to FDA documents, the Lintro-scan consisted of a movie projector light bulb as a near-infrared light source, a fiberoptic wand, and a videocamera and/or Polaroid camera.

I left out that the Lintro-scan also consisted of a cooling fan, a VCR, a character generator, and monitor.